Fifth Disease (Parvovirus B19): Clinical Presentation and Management

Overview of Fifth Disease

Fifth disease, also known as erythema infectiosum, is a common viral exanthem in children caused by human parvovirus B19. The condition earned its name historically as the fifth recognized childhood exanthem, following measles (first disease), scarlet fever (second disease), rubella (third disease), and roseola (sixth disease). Fifth disease typically affects children between 5-14 years of age, though it can occur at any age, and occurs more commonly in late winter and spring. The disease is characterized by a distinctive facial rash with a "slapped cheek" appearance, followed by a lacy, reticular rash on the trunk and extremities. While the rash is the most recognizable feature, parvovirus B19 can cause systemic manifestations including constitutional symptoms, arthralgias, and in immunocompromised patients, severe anemia and persistent infection.

Epidemiology and Transmission

Human parvovirus B19 is a small, non-enveloped DNA virus belonging to the Parvoviridae family. Transmission occurs through respiratory droplets, making the infection readily spreadable in school and daycare settings. Approximately 1-6% of children develop clinical fifth disease annually in temperate climates, with higher rates during epidemics. Seroprevalence studies indicate that 50% of children acquire parvovirus B19 infection by age 5 and 90% by adulthood, meaning most individuals develop immunity by early adulthood. The incubation period ranges from 4-14 days, with an average of 7-10 days. Patients are most infectious during the prodromal phase before rash development, when viremia is highest. Infectivity decreases significantly once the rash appears, meaning children with visible rashes are no longer considered highly contagious. This timing complicates infection control, as children are most contagious before diagnosis.

Clinical Presentation and Course

Fifth disease typically begins with a nonspecific prodromal phase characterized by low-grade fever, malaise, headache, fatigue, and upper respiratory symptoms such as cough or sore throat lasting 2-7 days. This prodrome is nonspecific and indistinguishable from common viral infections. The distinctive rash then develops, typically appearing first on the cheeks as intense erythema with a characteristic "slapped cheek" appearance, giving the child the appearance of having been struck across the face. The perioral area typically remains spared, creating a distinctive appearance. Over 1-3 days, the rash spreads to the trunk and extremities, developing a characteristic lacy or reticular pattern that blanches with pressure. The rash may appear and disappear episodically, particularly with temperature changes, sunlight exposure, or emotional stress, sometimes persisting for several weeks. Constitutional symptoms usually improve as the rash develops, and most children feel significantly better despite the visible rash.

Systemic Manifestations and Complications

While the rash is the hallmark of fifth disease, parvovirus B19 frequently causes systemic symptoms, particularly joint and muscle involvement. Children commonly experience myalgias and arthralgias affecting the small joints of the hands, knees, and ankles, typically lasting several days to weeks. Older children and especially adolescents may report significant joint pain. Adults, particularly women, experience arthropathy far more commonly than children, with symmetric polyarticular arthritis affecting the hands, wrists, knees, and ankles. This arthritis can persist for weeks to months and in some cases shows chronicity. Systemic manifestations may include headache, fever, sore throat, and gastrointestinal symptoms such as nausea, vomiting, or diarrhea. Serious complications are rare in immunocompetent children but include myocarditis (rare), aplastic crisis in patients with underlying hemolytic anemias, and persistent infection in immunocompromised individuals. Pregnant women infected with parvovirus B19 face risk of vertical transmission and potential fetal complications including hydrops fetalis and fetal loss, though most pregnancies continue normally.

Diagnosis and Differentiation

Diagnosis is primarily clinical in children presenting with the characteristic "slapped cheek" facial rash followed by reticular trunk rash. The clinical presentation is distinctive enough that serological testing is typically unnecessary. When confirmation is desired, serological testing for parvovirus B19-specific IgM antibodies indicates acute infection, while IgG antibodies indicate past exposure and immunity. PCR testing detecting parvovirus B19 DNA is highly sensitive but typically reserved for immunocompromised patients or pregnant women with suspected infection. Differential diagnosis includes measles (maculopapular rash, higher fever, cough), rubella (rash with lymphadenopathy), scarlet fever (sandpaper-like rash with strawberry tongue), roseola (high fever followed by rash), and other viral exanthems. The distinctive slapped cheek appearance and lacy reticular pattern typically allow accurate diagnosis without additional testing in immunocompetent children.

Management and Treatment

Management of fifth disease is supportive, as no specific antiviral therapy is indicated for immunocompetent patients. Treatment focuses on symptomatic relief including acetaminophen or ibuprofen for fever and joint pain, adequate hydration, and rest. Most children recover completely within 1-2 weeks, though the rash may episodically recur for weeks. Infected children may return to school or daycare once they feel well enough to attend and are afebrile, as infectivity is minimal once rash develops. No isolation beyond standard precautions is necessary. Immunocompromised patients, including those with HIV/AIDS or hematologic malignancies, may develop severe anemia requiring transfusion and may benefit from intravenous immunoglobulin (IVIG) therapy. Pregnant women suspected of parvovirus infection warrant close fetal monitoring via ultrasound to detect hydrops fetalis or other complications.

Frequently Asked Questions

Is fifth disease serious? Fifth disease is generally mild and self-limited in healthy children. The rash may be concerning to parents, but serious complications are rare in immunocompetent children.

Can my child go to school with the rash? Yes. Once the rash appears, infectivity is minimal. Children may return to school once they feel well and are afebrile, though some schools may have attendance policies requiring medical clearance.

Is this contagious to pregnant women? Yes, parvovirus B19 can be transmitted to pregnant women. While most pregnant women fare well, infection carries risk of fetal complications and warrants close monitoring.

Will the rash leave scars? No. Fifth disease rashes do not scar or leave permanent pigmentary changes. The skin returns to completely normal appearance after resolution.

How long does the rash last? The initial rash typically lasts 1-3 weeks, but the rash may recur episodically with temperature changes or stress for additional weeks.

References